Mokaleng’s project looks at optimising the recently improved Long-Range HIV Genotyping for Analysis of HIV Drug Resistance and HIV Clustering in the Botswana population. In this project, they...
With an intense, generalised HIV epidemic affecting all social strata and a strong programme to treat HIV and malignancies, Botswana provides a unique opportunity to address questions pertaining to...
This will be the first study to report on the prevailing M. tuberculosis genotypes in Botswana and their association with HIV co-infection. This study also presents the first overview of M...
HIV-1 drug resistance genotyping has become a standard of care in HIV-1 infection management in developed countries but availability remains infrequent in the developing world. In Botswana, all HIV...
HIV-1 neutralising and non-neutralising antibodies have been shown to play a role as correlates of protection from infection. It is important to determine the ability of these bnAbs to neutralise HIV...
The aim of Maseng’s project is to look at human genetic variation at the gene (Cytochrome P2B6) level as a possible host co-factor in selecting for non-nucleoside reverse transcriptase inhibitors (...
This project investigates the Prevalence of HIV-1 minor drug resistance variants in antiretroviral naive individuals in Botswana. Maruapula uses one of the cheaper, more sensitive assays, PAN...
Rantshabeng's study focuses on the high-risk Human papillomavirus (HPV) types that are associated with vulvar, penile, anal and cervical squamous cell carcinoma. Human papillomavirus (HPV) associated...